Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Biologicals : Journal of the International Association of Biological Standardization
|
September 2, 2009
Basic principles of stability
William Egan, Timothy Schofield
Biologicals : Journal of the International Association of Biological Standardization
|
September 2, 2008
New Cells for New Vaccines II: Focus on Respiratory Virus Diseases
William Egan, Geoffrey Schild
The Journal of Manual & Manipulative Therapy
|
January 15, 2014
The addition of manipulation to an extension-oriented intervention for a patient with chronic LBP
Heidi Ojha, William Egan, Patricia Crane
The American Journal of Emergency Medicine
|
June 4, 2018
Vitamin B<sub>12</sub> deficiency-induced neuropathy secondary to prolonged recreational use of nitrous oxide
William Egan, Eric Steinberg, Jeremy Rose
Vaccine
|
August 20, 2002
Aluminum salts in vaccines--US perspective
Norman W Baylor, William Egan, Paul Richman
Biologicals : Journal of the International Association of Biological Standardization
|
October 11, 2011
Post-licensure evaluation of vaccine safety: current status and future directions. Symposium organised by the International Alliance for Biological Standardization (IABS) in Barcelona, Spain, 27-28 April 2011
Steven Black, William Egan, Paul-Henri Lambert
Journal of the American Chemical Society
|
March 6, 2003
Conformational flexibility of the group B meningococcal polysaccharide in solution
Terry J Henderson, Richard M Venable, William Egan
Sports Health
|
September 28, 2012
Letter to the editor: response
Scott A Burns, William Egan, Paul Glynn, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
August 3, 2006
Potency assays for therapeutic live whole cell cancer vaccines
John Petricciani, William Egan, Giuseppe Vicari, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
June 12, 2010
Validation of the safety of MDCK cells as a substrate for the production of a cell-derived influenza vaccine
David Onions, William Egan, Ruth Jarrett, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Biologicals : Journal of the International Association of Biological Standardization
|
September 2, 2009
Basic principles of stability
William Egan, Timothy Schofield
Biologicals : Journal of the International Association of Biological Standardization
|
September 2, 2008
New Cells for New Vaccines II: Focus on Respiratory Virus Diseases
William Egan, Geoffrey Schild
The Journal of Manual & Manipulative Therapy
|
January 15, 2014
The addition of manipulation to an extension-oriented intervention for a patient with chronic LBP
Heidi Ojha, William Egan, Patricia Crane
The American Journal of Emergency Medicine
|
June 4, 2018
Vitamin B<sub>12</sub> deficiency-induced neuropathy secondary to prolonged recreational use of nitrous oxide
William Egan, Eric Steinberg, Jeremy Rose
Vaccine
|
August 20, 2002
Aluminum salts in vaccines--US perspective
Norman W Baylor, William Egan, Paul Richman
Biologicals : Journal of the International Association of Biological Standardization
|
October 11, 2011
Post-licensure evaluation of vaccine safety: current status and future directions. Symposium organised by the International Alliance for Biological Standardization (IABS) in Barcelona, Spain, 27-28 April 2011
Steven Black, William Egan, Paul-Henri Lambert
Journal of the American Chemical Society
|
March 6, 2003
Conformational flexibility of the group B meningococcal polysaccharide in solution
Terry J Henderson, Richard M Venable, William Egan
Sports Health
|
September 28, 2012
Letter to the editor: response
Scott A Burns, William Egan, Paul Glynn, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
August 3, 2006
Potency assays for therapeutic live whole cell cancer vaccines
John Petricciani, William Egan, Giuseppe Vicari, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
June 12, 2010
Validation of the safety of MDCK cells as a substrate for the production of a cell-derived influenza vaccine
David Onions, William Egan, Ruth Jarrett, et al.
Page
of 2